• Mashup Score: 2

    Gadolinium-based contrast agents (GBCA) improve the diagnostic capabilities of magnetic resonance imaging. Although initially believed to be without major adverse effects, GBCA use in patients with severe chronic kidney disease (CKD) was demonstrated to cause nephrogenic systemic fibrosis (NSF). Restrictive policies of GBCA use in CKD and selective use of GBCAs which bind free gadolinium (Gd+3)…

    Tweet Tweets with this article
    • Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review https://t.co/WicurzjXgD (FREE temporarily) @MichaelRudnick7 @AmandaLeonberg @PennKidney #gadolinium #AKI #CKD #kidneydisease https://t.co/sOocvrl0Sn

  • Mashup Score: 0

    October 29, 2020 — Contrast agents used to improve views of the heart on magnetic resonance imaging (MRI) carry a very low risk of allergic reactions, vomiting and other acute adverse events, according to a large study from Europe published in Radiology: Cardiothoracic Imaging.[1] The findings come three years after the European Union enacted new regulations on the contrast agents.

    Tweet Tweets with this article
    • Cardiac MRI Contrast Agents Carry Low Risk of Adverse Events https://t.co/JOyFGk1asg #MRI #cardiacMRI #cardiotwitter #radiology #gadolinium

  • Mashup Score: 3

    Gadolinium-based contrast agents (GBCA) improve the diagnostic capabilities of magnetic resonance imaging. Although initially believed to be without major adverse effects, GBCA use in patients with severe chronic kidney disease (CKD) was demonstrated to cause nephrogenic systemic fibrosis (NSF). Restrictive policies of GBCA use in CKD and selective use of GBCAs which bind free gadolinium (Gd+3)…

    Tweet Tweets with this article
    • Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review https://t.co/b0dJoMTrya (FREE temporarily) @MichaelRudnick7 @AmandaLeonberg @PennKidney #gadolinium #AKI #CKD #kidneydisease https://t.co/BwBhmiewVi

  • Mashup Score: 6

    Gadolinium-based contrast agents (GBCA) improve the diagnostic capabilities of magnetic resonance imaging. Although initially believed to be without major adverse effects, GBCA use in patients with severe chronic kidney disease (CKD) was demonstrated to cause nephrogenic systemic fibrosis (NSF). Restrictive policies of GBCA use in CKD and selective use of GBCAs which bind free gadolinium (Gd+3)…

    Tweet Tweets with this article
    • Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review https://t.co/b0dJoMTrya (FREE temporarily) @MichaelRudnick7 @AmandaLeonberg @PennKidney #gadolinium #AKI #CKD #kidneydisease https://t.co/ih292hBguj

  • Mashup Score: 2

    Gadolinium-based contrast agents (GBCAs) are molecularly heterogeneous with various chelates holding the paramagnetic element gadolinium. Chelates are either linear or macrocyclic, ionic or nonionic (Table 11-5). Historically, nephrologists did not differentiate among these agents. About 2 decades ago, the novel entity nephrogenic systemic fibrosis (NSF) was first reported by Cowper et al6 in…

    Tweet Tweets with this article
    • Use of Gadolinium-Based Contrast Agents in Kidney Disease Patients: Time for Change https://t.co/EiJjNoc1aK (FREE) @Abualfaa #gadolinium #CKD https://t.co/BB8VN3NlrW

  • Mashup Score: 4

    Recent evidence in animal studies indicates that gadolinium side effects may be more likely in the skin than the brain, making it important that research into gadolinium deposition swtich its focus to the skin and its innervation, a leading European investigator has suggested.

    Tweet Tweets with this article
    • New results of study in @radiology_rsna could explain the neuropathic pain of patients following #gadolinium injections, and researchers "have an ethical obligation to assess the potential side effects of gadolinium exposure." #radiology MRI https://t.co/fAgLlNX9Ji https://t.co/Zw5bAmnz1G

  • Mashup Score: 6

    Gadolinium-based contrast agents (GBCA) improve the diagnostic capabilities of magnetic resonance imaging. Although initially believed to be without major adverse effects, GBCA use in patients with severe chronic kidney disease (CKD) was demonstrated to cause nephrogenic systemic fibrosis (NSF). Restrictive policies of GBCA use in CKD and selective use of GBCAs which bind free gadolinium (Gd+3)…

    Tweet Tweets with this article
    • Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review https://t.co/WicurzjXgD @MichaelRudnick7 @AmandaLeonberg @PennKidney #gadolinium #AKI #CKD #kidneydisease https://t.co/RzkLv1yIz2

  • Mashup Score: 0

    Patients use Twitter to post feedback about their MRI experiences, and although more than 60% of those tweets mention gadolinium-based contrast agents (GBCAs), less than 10% specifically address gadolinium retention, according to a case study published August 18 in the Journal of the American College of Radiology.

    Tweet Tweets with this article
    • Patients use Twitter to post feedback about their MRI experiences, and although more than 60% of those tweets mention gadolinium-based contrast agents (GBCAs), less than 10% specifically address #gadolinium retention. #MRI #radiology https://t.co/ozsF9KFoXu https://t.co/OtLAkb8D84

  • Mashup Score: 1

    As concerns about the safety of gadolinium-based MRI contrast persist, radiologists should know that they have a number of alternatives to gadolinium, according to presentations on August 9 at the Society for MR Radiographers & Technologists virtual meeting.

    Tweet Tweets with this article
    • Radiologists should know that they have a number of alternatives to #gadolinium MRI contrast, according to talks on August 9 at the SMRT virtual meeting. #ISMRM20 #MRI @SMRT_ISMRM @ISMRM #radiology https://t.co/6YRolEIMKU https://t.co/52qNKCeCnM